Kazia Therapeutics Ltd
F:NV9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kazia Therapeutics Ltd
F:NV9
|
AU |
Dividends
Dividend Yield
Kazia Therapeutics Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Kazia Therapeutics Ltd
NV9 have decreased by 0%.
Payout Ratio
Kazia Therapeutics Ltd
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
NV9 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
NV9 Price
Kazia Therapeutics Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -29% |
| Market Capitalization | 18.2m EUR |
| Shares Outstanding | 149 637 000 |
| Percentage of Shares Shorted |
N/A
|
NV9 Return Decomposition
Main factors of price return
Stock Splits
NV9's latest stock split occurred on Nov 17, 2017
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, NV9 traded at 0.023 per share. Afterward, the share price was about 0.23.
The adjusted shares began trading on Nov 17, 2017. This was the only stock split in NV9's history.